Mylan - Better Health for a Better World

Loading the player...

U.S. FDA Approves Wixela^TM Inhub^TM (fluticasone propionate and salmeterol inhalation powder, USP)

Discover How Mylan is Delivering Better Health

Delivering better health isn’t our job, it’s our mission

See how Mylan is making an impact in your part of the world

Mylan has a portfolio of 7,500+ marketed products

Including biosimilars, generics, brand products and OTC remedies

A leading voice in healthcare

CEO Heather Bresch's Blog

See how Mylan is setting new standards in global healthcare as we increase access to medicine

Mylan releases fourth quarter 2018 and year-end financial results

Learn why good isn't good enough for Mylan

Read about an emotional homecoming in Puerto Rico

Helping lead the fight against HIV/AIDS

One Career Can Change the Lives of Many

Every Mylan employee works to impact the lives of 7 billion people around the world

Search career opportunities

Discover who we are